Cell-containing structure
A cell-containing structure is provided that allows ready-to-use nerve drug response evaluation with high reproducibility to be easily performed. The cell-containing structure for evaluating an electrical property of neurons includes: (a) a culture surface to which the neurons are able to be adhered; (b) a cell mass that is adhered to the culture surface and contains at least one of the neurons; and (c) a plurality of electrodes for measuring the electrical property of the cell mass, wherein a spontaneous firing frequency of cells contained in the cell mass is 0.25 Hz or more per electrode.
1 . A method for preparing a cell-containing structure for evaluating an electrical property of neurons, comprising:
1) providing a cell containing structures comprising
(a) a culture surface coated with a coating agent to which the neurons are able to be adhered;
(b) a cell mass that is adhered to the coated culture surface and contains the neurons; and
(c) a plurality of electrodes for measuring the electrical property of the cell mass,
2) determining a spontaneous firing frequency of cells contained in the cell mass and
3) retaining the cell-containing structures where the spontaneous firing frequency of cells contained in the cell mass is 0.25 Hz or more and less than 31.25 Hz, per electrode, thereby preparing a cell-containing structure for evaluating an electrical property of neurons.
2 . The method according to claim 1 ,
wherein the neurons are neurons obtained by in vitro differentiation.
3 . The method according to claim 1 ,
wherein the neurons are neurons derived from human artificial pluripotent stem cells (hiPSC).
4 . The method according to claim 3 ,
wherein the human artificial pluripotent stem cells are derived from healthy people.
5 . The method according to claim 3 ,
wherein the human artificial pluripotent stem cells are derived from a human having a disease.
6 . The method according to claim 5 ,
wherein the disease is a nervous disease.
7 . The method according to claim 5 ,
wherein the disease is autism, epilepsy, schizophrenia, ADHD, ALS or bipolar disorder.
8 . The method according to claim 1 ,
wherein the cell mass contains astrocytes.
9 . The method according to claim 1 ,
wherein the cell mass contains microglial cells or oligodendrocytes.
10 . The method according to claim 1 , further comprising a substrate which is an extracellular matrix.
11 . The method according to claim 10 ,
wherein the extracellular matrix contains laminin.
12 . The method according to claim 1 ,
wherein the electrical property is detected by a response to at least one stimulus treatment applied to the cell mass.
13 . The method according to claim 12 ,
wherein the stimulus treatment is exposure to at least one test compound.
14 . The method according to claim 13 ,
wherein the test compound is an agonist or antagonist of a neurotransmitter receptor.
15 . The method according to claim 13 ,
wherein the test compound is an ion channel blocker.